HQY
HealthEquity, Inc. · Healthcare · Medical - Healthcare Information Services
动量输入(同类管理人): 持有人广度 0.0% · 股份流向 +2.7% · 净新建仓位 0.0% · 公式
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q1 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 66.73K | $5.23M | n/a | n/a |
| Q2 2026 | 121 | -1 | 56.85M | $5.13B | +6 | −6 |
| Q1 2026 | 124 | -5 | 55.96M | $4.67B | +5 | −11 |
| Q4 2025 | 129 | 0 | 62.94M | $5.77B | +1 | n/a |
| Q3 2025 | 18 | 0 | 39.21M | $3.72B | +2 | −3 |
| Q2 2025 | 16 | +2 | 35.13M | $3.68B | +4 | −2 |
| Q1 2025 | 11 | 0 | 9.21M | $813.19M | +1 | −1 |
| Q4 2024 | 11 | -1 | 8.97M | $860.26M | +1 | −2 |
| Q3 2024 | 11 | -3 | 5.31M | $434.71M | n/a | −3 |
| Q2 2024 | 14 | n/a | 5.18M | $446.62M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 3.28M | +0.5% | $289.86M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 2.14M | +2.6% | $189.40M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 848.94K | +24.9% | $75.02M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 4 | Norges Bank ✦ (被动) | 777.27K | -0.2% | $68.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 639.35K | +995.6% | $56.50M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 588.69K | -60.8% | $52.02M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 445.65K | +89.9% | $38.54M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 8 | Citadel Advisors ✦ | 433.24K | +30.3% | $38.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 32.20K | 新增 | $2.85M | 0.0% | New | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 12.00K | +50.0% | $1.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 11.00K | -20.4% | $972,070 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $2.85M | 0.0% |
已清仓
| Arrowstreet Capital | $639,603 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 482 持有人, 85.01M 股份, $6.90B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
Officer · EVP Chief Prod &… · 108 股 @ 90.33 · $9,756
Officer · EVP Chief Prod &… · 23 股 @ 95.06 · $2,186
公开市场卖出 (S)
Director · 1.33K 股 · $140,201
Director · 6.30K 股 · $658,172
Officer · 108 股 · $11,405
Officer · 23 股 · $1,905
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论